Our findings underscore the urgent need for specifically designed trials in SCD populations to establish the feasibility, effectiveness, and clinical relevance of VR interventions at this very early stage of cognitive decline
National Library of Medicine, accessed 20 Jan 2021, Ruggenenti, P 2013, Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)
However, cipemastat, a selective MMP inhibitor, paradoxically increased cavitation, immunopathology, and mortality in a murine model of cavitary TB [139]
Safety Concerns Although ketamine has promise, several potential adverse events must be taken into consideration during individual selection and monitoring of treatment
10.1016/S1081-1206(10)61783-8
10.1016/S0966-842X(00)01936-3 Trends Microbiol